Adherium Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Public

  • Stock Symbol
  • ADRDA

Stock Symbol

Adherium General Information

Description

Adherium Ltd is engaged in the development, manufacture, and supply of its Hailie digital health technologies that address sub-optimal medication use and improve health outcomes in chronic disease. Geographically, it derives a majority of its revenue from Europe and also has a presence in New Zealand and Australia; North America, and Asia.

Contact Information

Website
www.adherium.com
Formerly Known As
Nexus6
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Level 2, 63 Albert Street
  • PO Box 106612
  • Auckland, 1010
  • New Zealand
+64 09-307
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Monitoring Equipment
Stock Exchange
ASX
Vertical(s)
Manufacturing
Corporate Office
  • Level 2, 63 Albert Street
  • PO Box 106612
  • Auckland, 1010
  • New Zealand
+64 09-307

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Adherium Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$7.17M 759M 1.08M

Adherium Financials Summary

In Thousands,
USD 		TTM 30-Jun-2024 FY 2024 30-Jun-2024 FY 2023 30-Jun-2023 FY 2022 30-Jun-2022
EV 6,611 6,611 2,294 7,058
Revenue 2,148 383
EBITDA (6,631) (8,018)
Net Income (6,627) (8,134)
Total Assets 8,394 5,063
Total Debt 29 58
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Adherium Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Adherium‘s full profile, request access.

Request a free trial

Adherium Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Adherium Ltd is engaged in the development, manufacture, and supply of its Hailie digital health technologies that addre
Therapeutic Devices
Auckland, New Zealand

Amsterdam, Netherlands
 

Milan, Italy
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Adherium Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Philips Corporation Amsterdam, Netherlands
Amiko Venture Capital-Backed Milan, Italy
You’re viewing 2 of 2 competitors. Get the full list »

Adherium Patents

  • 103

    Total Documents Applications and Grants

  • Total Patents Families

  • 87

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

Adherium Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-D983962-S1 Compliance monitor for a medicament infuser Active 08-Jul-2021
US-D994113-S1 Compliance monitor for dry powder inhaler Active 05-Nov-2020
US-D991440-S1 Compliance monitor for metered dose inhaler Active 05-Nov-2020
AU-201814618-S A compliance monitor for a medicament inhaler Active 15-Feb-2018
AU-201814619-S A compliance monitor for a medicament inhaler Active 15-Feb-2018
To view Adherium’s complete patent history, request access »

Adherium Executive Team (14)

Name Title Board Seat
Paul Mastoridis Chief Executive Officer
Daniel Kaplon Chief Financial Officer
Francis White Chief Operating Officer
Luke Allera Director of Sales and Sales Operations
You’re viewing 4 of 14 executive team members. Get the full list »

Adherium Board Members (6)

Name Representing Role Since
Jeremy Cook Self Board Member
Maxine Simmons Self Board Member
You’re viewing 2 of 6 board members. Get the full list »

Adherium Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Adherium‘s full profile, request access.

Request a free trial

Adherium ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Health Care IT Services

Subindustry

Rank

Percentile

To view Adherium’s complete esg history, request access »

Adherium FAQs

  • When was Adherium founded?

    Adherium was founded in 2001.

  • Who is the CEO of Adherium?

    Paul Mastoridis is the CEO of Adherium.

  • Where is Adherium headquartered?

    Adherium is headquartered in Auckland, New Zealand.

  • What industry is Adherium in?

    Adherium’s primary industry is Therapeutic Devices.

  • Is Adherium a private or public company?

    Adherium is a Public company.

  • What is Adherium’s stock symbol?

    The ticker symbol for Adherium is ADRDA.

  • What is the current market cap of Adherium?

    The current market capitalization of Adherium is $7.17M.

  • Who are Adherium’s competitors?

    Philips and Amiko are competitors of Adherium.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »